EGFR and pulmonary fibrosis: These results indicated that HMGB1 contributed to the pulmonary fibrosis and gefitinib attenuated bleomycin-induced collagen deposition and excessive oxidative stress, mainly by suppressing the HMGB1/NOXs-ROS/EGFR-MAPKs-AP-1/NF-κB signal.